Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease

Marcus M. Ilg(Chelmsford and Essex Hospital), Selim Cellek(University College London)
The Journal of Sexual Medicine
August 5, 2020
Cited by 25


Related Papers